Petros Pharmaceuticals Inc (PTPI)
US$ 0.0545.47%
Price Chart
Key Statistics
Market Cap
$ 2.89M
P/E Ratio
0.00
Revenue (TTM)
$ 5.11M
Volume
2.49M
52W High
$ 0.77
52W Low
$ 0.04
Dividend Yield
0.00%
Beta
2.09
Technicals
50-Day MA
0.0889
200-Day MA
0.2781
52 Week High
0.766
52 Week Low
0.036
About PTPI
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally.
Employees
18
Headquarters
New York, NY
CEO
Mr. Fady Boctor M.B.A.
Latest News
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
2025-03-26 • Google News
Petros Pharmaceuticals faces delisting, stockholders approve equity changes - Investing.com
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg